Navigation Links
MediVet-America, Leading Animal Stem Cell Developer, Launches MediVet Lab Services

NICHOLASVILLE, Ky., Feb. 1, 2011 /PRNewswire/ -- MediVet-America today announced the opening of MediVet Lab Services in Lexington, Kentucky, to provide technical support for in-clinic animal stem cell procedures, regional and national Adipose Stem Cell Processing, Cryogenic Banking Services, Autologous Conditional Serum Processing, and Cell Counting Services for in-house stem cell treatments.

MediVet-America, the leading developer of stem cell regenerative therapy for adult animals suffering from osteoarthritis, hip dysplasia, ligament and cartilage injuries and other degenerative diseases, already provides equipment that allows veterinarians to perform Adipose Stem Cell procedures completely in-house. This new service will provide vets with access to a range of services, including processing of adipose tissue to extract adult stem cells.

MediVet Lab Services features a dedicated research and development department, a cell biologist and support staff.  MediVet-America Managing Director Jeremy Delk envisions opening additional laboratories throughout the U.S., providing an interactive web site offering vet certification and a quality assurance/control program for cell counting and banking.

"MediVet-America is the only veterinary stem cell company that has developed its own technology and protocols," said Delk.  "We do not simply license the research of others. Our researchers and cell biologists ensure we stay on the forefront of this exciting technology. Furthermore, we are the only company offering a complete, one-stop range of affordable veterinary stem cell services for all veterinarians."

MediVet-America pioneered the in-clinic animal stem cell therapy market. Since March 1, 2010, the company has signed agreements with more than 100 leading veterinarians across the U.S. and distributes the technology in eight countries worldwide. Veterinarians are seeing tremendous results; within weeks of a procedure, animals that had been lame, unable to climb stairs or jump up are walking, running and playing.

Delk added that with no processing/culture fee, MediVet Lab Services makes banked doses more affordable, with the ability to return large numbers of viable first generation cells.

"Our banked-dose recovery fee is as much as 35 percent less than other companies," said Delk.

ABOUT MEDIVET-AMERICAA research and development company and global leader in veterinary stem cell technology, MediVet-America provides innovative cell technology applications for the therapeutic care of animals.  Headquartered in Nicholasville, Kentucky, MediVet-America develops advanced cellular designed kits and services for the treatment of osteoarthritis and degenerative joint disease. www.MediVet-America.comCONTACT:

Dick RobertsRoberts Communicationsv:  412-535-5000

SOURCE MediVet-America
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
2. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
3. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
4. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
5. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
6. ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
7. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
8. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
9. Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant
10. Patent Technologies Keep CGMT in a Leading Position in the Industry
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... Manufacturing Practice (GMP) 10000 in the Santiago Marriott. The Global Stem Cells Group ... by a world-class team of qualified medical researchers and practitioners, experienced in administering ...
(Date:11/30/2015)... includes an MPP licen c ... , s Solid Drug Nanoparticle (SDN) Technology ; Aims ... through cost cuts of priority ... anywhere in the world will have the right to make, use and distribute lower ... licensees based anywhere in the world will have the right to make, use and ...
(Date:11/30/2015)... Md. , Nov. 30, 2015 ... development company committed to the fostering and monetization ... the current and prospective initiatives designed to create ... Chief Executive Officer of Spherix. "Based on published ... future licensees exceeds $50 billion and Spherix will ...
(Date:11/30/2015)... JACKSONVILLE, Florida , November 30, 2015 ... company specializing in the development of innovative peptide and ... & metastatic disease, today announced it will be presenting ... Event on December 1, 2015 at 2.30 PM PT. ... member and Strategic Advisor will be giving the presentation ...
Breaking Biology Technology:
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
(Date:11/4/2015)... 2015 --> ... by Transparency Market Research "Home Security Solutions Market - Global ... - 2022", the global home security solutions market is expected to ... The market is estimated to expand at a CAGR ... 2022. Rising security needs among customers at homes, the ...
Breaking Biology News(10 mins):